Thomas M. Ellis

2.9k total citations · 1 hit paper
66 papers, 2.3k citations indexed

About

Thomas M. Ellis is a scholar working on Immunology, Transplantation and Surgery. According to data from OpenAlex, Thomas M. Ellis has authored 66 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 24 papers in Transplantation and 18 papers in Surgery. Recurrent topics in Thomas M. Ellis's work include Renal Transplantation Outcomes and Treatments (24 papers), Immune Cell Function and Interaction (19 papers) and T-cell and B-cell Immunology (15 papers). Thomas M. Ellis is often cited by papers focused on Renal Transplantation Outcomes and Treatments (24 papers), Immune Cell Function and Interaction (19 papers) and T-cell and B-cell Immunology (15 papers). Thomas M. Ellis collaborates with scholars based in United States, Netherlands and Australia. Thomas M. Ellis's co-authors include Richard I. Fisher, Arjang Djamali, Dixon B. Kaufman, Hans‐Martin Jäck, Weixiong Zhong, Millie Samaniego, Arthur J. Matas, Robert C. Flanigan, Eugene D. Kwon and Patricia Simms and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Thomas M. Ellis

66 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches

2014 276 citations Arjang Djamali, Dixon B. Kaufman et al. American Journal of Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas M. Ellis United States	26	1.1k	857	640	444	310	66	2.3k
Kammi Henriksen United States	19	1.8k 1.7×	390 0.5×	390 0.6×	520 1.2×	348 1.1×	52	3.0k
Michael Eikmans Netherlands	30	988 0.9×	674 0.8×	546 0.9×	194 0.4×	641 2.1×	108	2.8k
Christopher Siegel United States	21	605 0.6×	524 0.6×	698 1.1×	751 1.7×	535 1.7×	51	2.4k
Anthony Dorling United Kingdom	35	1.1k 1.0×	849 1.0×	1.9k 2.9×	164 0.4×	507 1.6×	144	3.6k
T. Mohanakumar United States	31	815 0.8×	716 0.8×	1.5k 2.4×	242 0.5×	435 1.4×	106	2.7k
Sebastiaan Heidt Netherlands	30	1.1k 1.0×	1.2k 1.4×	802 1.3×	216 0.5×	325 1.0×	130	2.5k
Anna Valujskikh United States	32	2.3k 2.1×	1.0k 1.2×	695 1.1×	264 0.6×	405 1.3×	89	3.2k
Alan Ting United Kingdom	22	996 0.9×	593 0.7×	466 0.7×	161 0.4×	248 0.8×	40	2.1k
A. Bernard Collins United States	22	955 0.9×	1.7k 2.0×	1.0k 1.6×	147 0.3×	193 0.6×	36	2.8k
Sylvie Ferrari‐Lacraz Switzerland	20	1.0k 0.9×	320 0.4×	338 0.5×	344 0.8×	352 1.1×	60	1.9k

Countries citing papers authored by Thomas M. Ellis

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Ellis more than expected).

Fields of papers citing papers by Thomas M. Ellis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Ellis. The network helps show where Thomas M. Ellis may publish in the future.

Co-authorship network of co-authors of Thomas M. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Ellis. A scholar is included among the top collaborators of Thomas M. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Ellis. Thomas M. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Redfield, Robert R., Thomas M. Ellis, Weixiong Zhong, et al.. (2016). Current outcomes of chronic active antibody mediated rejection – A large single center retrospective review using the updated BANFF 2013 criteria. Human Immunology. 77(4). 346–352. 68 indexed citations

Sackett, Sara Dutton, Matthew E. Brown, Daniel M. Tremmel, et al.. (2016). Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation. Transplantation Reviews. 30(2). 61–70. 20 indexed citations

Schiller, Jennifer, Yong-ran Zhu, Sundaram Hariharan, et al.. (2015). Renal Transplantation With Final Allocation Based on the Virtual Crossmatch. American Journal of Transplantation. 16(5). 1503–1515. 47 indexed citations

Musat, Alexandru I., Thomas M. Ellis, Rashmi Agni, et al.. (2013). Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation. Liver Transplantation. 19(10). 1132–1141. 43 indexed citations

Ellis, Thomas M., Jennifer Schiller, Allan M. Roza, et al.. (2012). Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength. Human Immunology. 73(7). 706–710. 40 indexed citations

Schiller, Jennifer, et al.. (2011). A novel HLA allele derived from a likely DRB1/DRB3 gene conversion event: HLA‐DRB3*01:15. Tissue Antigens. 78(5). 405–407. 1 indexed citations

Ehrman, Robert R., Charles Wira, Alison Hayward, et al.. (2011). Etomidate use in severe sepsis and septic shock patients does not contribute to mortality. Internal and Emergency Medicine. 6(3). 253–257. 11 indexed citations

Spellman, Stephen R., Michael Haagenson, Bradley C. Pietz, et al.. (2009). Effects of Mismatching for Minor Histocompatibility Antigens on Clinical Outcomes in HLA-Matched, Unrelated Hematopoietic Stem Cell Transplants. Biology of Blood and Marrow Transplantation. 15(7). 856–863. 41 indexed citations

Zangwill, Steven, et al.. (2007). Practical application of the virtual crossmatch. Pediatric Transplantation. 11(6). 650–654. 53 indexed citations

10.

Le, Phong T., et al.. (2001). Human Thymic Epithelial Cells Inhibit IL-15- and IL-2-Driven Differentiation of NK Cells from the Early Human Thymic Progenitors. The Journal of Immunology. 166(4). 2194–2201. 5 indexed citations

11.

Beck, Gregory, et al.. (2001). Nitric oxide production by coelomocytes of Asterias forbesi. Developmental & Comparative Immunology. 25(1). 1–10. 24 indexed citations

12.

Ellis, Thomas M., et al.. (1999). Serological evidence of an Australian bovine lentivirus. Veterinary Microbiology. 68(1-2). 171–177. 20 indexed citations

13.

Markham, Penelope N., Thomas M. Ellis, Anat R. Tambur, & Howard M. Gebel. (1996). DIFFERENTIAL SENSITIVITY OF RESTING AND IL-2 ACTIVATED NK CELLS TO R-VERAPAMIL1,2. Transplantation. 62(12). 1883–1888. 1 indexed citations

14.

Ellis, Thomas M., et al.. (1996). CD2 Regulates T Cell-Dependent Induction of Monocyte IL-1β mRNA during Anti-CD3 Mitogenesis. Cellular Immunology. 170(1). 120–126. 7 indexed citations

15.

Jäck, Hans‐Martin, et al.. (1996). Interleukin‐12 Activates Interferon‐γ Production by Targeted Activation of CD30⁺ T cellsa. Annals of the New York Academy of Sciences. 795(1). 127–136. 1 indexed citations

16.

Jäck, Hans‐Martin, et al.. (1995). IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells.. The Journal of Immunology. 154(1). 9–16. 45 indexed citations

17.

Ellis, Thomas M., et al.. (1993). CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells.. The Journal of Immunology. 151(5). 2380–2389. 177 indexed citations

18.

Pieper, Russell O., Bernard W. Futscher, Qing Dong, Thomas M. Ellis, & Leonard C. Erickson. (1990). Comparison of O-6-MethyIguanine DNA Methyltransferase (MGMT) mRNA Levels in Mer⁺ and Mer⁻ Human Tumor Cell Lines Containing the MGMT Gene by the Polymerase Chain Reaction Technique. PubMed. 2(1). 13–20. 67 indexed citations

19.

Creekmore, Stephen P., James Harris, Thomas M. Ellis, et al.. (1989). A phase I clinical trial of recombinant interleukin-2 by periodic 24-hour intravenous infusions.. Journal of Clinical Oncology. 7(2). 276–284. 42 indexed citations

20.

Ellis, Thomas M., et al.. (1988). Interleukin-1-independent activation of human T lymphocytes stimulated by anti-CD3 and a Hodgkin's disease cell line with accessory cell activity. Cellular Immunology. 116(2). 352–366. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact